Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page update introduces revision v3.5.4, replacing the previous v3.5.3. This appears to be a metadata/versioning change without visible user-facing content alterations.
    Difference
    0.1%
    Check dated 2026-05-16T10:05:41.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a website release rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T22:20:20.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:07:40.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:41.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  9. Check
    115 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1. This is a minor site version update that does not change study details.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:02.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.